scholarly journals Ogilvie Syndrome and COVID-19 Infection

2021 ◽  
Vol 12 (8) ◽  
pp. 328-331
Author(s):  
Jing Wang ◽  
Georgiana Marusca ◽  
Tooba Tariq ◽  
Bashar Mohamad
Keyword(s):  
Ogilvie Syndrome

Herpes zoster: a rare cause of Ogilvie syndrome

2021 ◽  
Author(s):  
Cheyaanthan Haran ◽  
Richard John Kyngdon
Keyword(s):  
Herpes Zoster ◽  
Ogilvie Syndrome

Acute Colonic Pseudo-Obstruction (Ogilvie syndrome) Following Primary Spinal Fusion: An Analysis of Outcomes and Risk Factors from 2005 to 2014

2021 ◽  
Author(s):  
Clark J. Chen ◽  
Akash A. Shah ◽  
Peter P. Hsiue ◽  
Ajith K. Subhash ◽  
Elizabeth L. Lord ◽  
...  
Keyword(s):  
Risk Factors ◽  
Spinal Fusion ◽  
Ogilvie Syndrome

scholarly journals An Alternative Approach to the Terminal Management of Ogilvie Syndrome

2017 ◽  
Vol 11 (2) ◽  
pp. 352-358
Author(s):  
Daniel Galban ◽  
Joshua J. Baiel
Keyword(s):  
Quality Of Life ◽  
Surgical Resection ◽  
Medical Therapy ◽  
Subtotal Colectomy ◽  
Abdominal Discomfort ◽  
Conservative Approach ◽  
Replacement Surgery ◽  
Alternative Approach ◽  
Ogilvie Syndrome

Ogilvie syndrome is defined as colonic pseudo-obstruction due to nonmechanical causes. Mortality of nearly 50% is associated with perforation of the distended, pseudo-obstructed colon. While conservative medical therapy has proven to be beneficial in a majority of cases, >3% of patients have significant distention or perforation of the colon that warrants surgical resection. The case of a 48-year-old male with progressive abdominal discomfort and distention 12 days following knee replacement surgery is presented. He was subsequently diagnosed with colonic pseudo-obstruction and definitively treated with subtotal colectomy and colostomy. We propose that a more conservative approach to treatment of colonic pseudo-obstruction may prevent the need for colostomy, significantly improving quality of life.

Postpolypectomy Acute Colonic Pseudo-Obstruction: Ogilvie Syndrome

2010 ◽  
Vol 103 (7) ◽  
pp. 715-716
Author(s):  
Rizwan Kibria ◽  
Salma Akram ◽  
Khurram Abbass
Keyword(s):  
Ogilvie Syndrome

scholarly journals Dysmorphic neonatal syndrome and Ogilvie syndrome

2017 ◽  
Vol 85 (2) ◽  
pp. 148-153
Author(s):  
Marco Aurelio Rendón-Medina
Keyword(s):  
Ogilvie Syndrome

scholarly journals Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen

2020 ◽  
Vol 13 (3) ◽  
pp. 1171-1175 ◽  
Author(s):  
Hrishi Varayathu ◽  
Mansi Sandip Shah ◽  
Vinu Sarathy ◽  
Beulah Elsa Thomas ◽  
Vinayak Munirathnam ◽  
...  
Keyword(s):  
Germ Cell ◽  
Germ Cell Tumor ◽  
Cumulative Dose ◽  
Sensory Neuropathy ◽  
Cell Tumor ◽  
Electrolyte Imbalance ◽  
Peripheral Sensory Neuropathy ◽  
Ogilvie Syndrome ◽  
Intestinal Pseudo Obstruction ◽  
Peripheral Sensory

Ogilvie syndrome or intestinal pseudo-obstruction is a clinical syndrome characterized by autonomic imbalance affecting peristalsis of colon leading to obstructive signs and symptoms. The etiologies commonly implicated are drugs affecting the cholinergic system, narcotics, electrolyte imbalance, severe sepsis, cancer, major surgery, and renal and cardiac failure. Ogilvie syndrome secondary to chemotherapy is a very rare phenomenon with very few reports in the literature. Cisplatin-induced neuropathy has been reported to occur when the cumulative dose exceeds 360 mg/m<sup>2</sup>. It manifests predominantly as peripheral sensory neuropathy with autonomic neuropathy occurring very rarely in a subset of patients. All the reported cases to date who presented with autonomic dysfunction secondary to cisplatin also had peripheral sensory neuropathy. Herein, we report a case of metastatic nonseminomatous germ cell tumor treated with cisplatin based regimen, who presented with severe intestinal pseudo-obstruction when the cumulative dose exceeded 400 mg/m<sup>2</sup> without any other manifestation of neuropathy. To our knowledge this is the first such case reported in the literature.

Sign in / Sign up

Export Citation Format

Share Document